Table of Contents
HPB Surgery
Volume 2008, Article ID 684150, 10 pages
http://dx.doi.org/10.1155/2008/684150
Review Article

Management of the Hepatic Lymph Nodes during Resection of Liver Metastases from Colorectal Cancer: A Systematic Review

University Department of Surgery, UCL and Royal Free Hospital NHS Trust, Royal Free and University College School of Medicine, London NW3 2QG, UK

Received 7 March 2007; Accepted 22 June 2007

Academic Editor: Olivier Farges

Copyright © 2008 Kurinchi S. Gurusamy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Wood, S. Rowan, M. Quinn, and N. Cooper, “Cancer incidence and mortality in the United Kingdom, 2001–2003,” National Cancer Intelligence Centre, Office for National Statistics, 2005, http://www.statistics.gov.uk//downloads/theme_health/UK_inc&mort_finalxls.
  2. National Statistics, “Cancer,” 2005, http://www.statistics.gov.uk/CCI/nuggetasp?ID=920&38;Pos=2&38;ColRank=1&38;Rank=294.
  3. R. M. Goldberg, T. R. Fleming, C. M. Tangen et al., “Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection,” Annals of Internal Medicine, vol. 129, no. 1, pp. 27–35, 1998. View at Google Scholar
  4. J. E. Tepper, M. O'Connell, D. Hollis, D. Niedzwiecki, E. Cooke, and R. J. Mayer, “Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from intergroup study 0114,” Journal of Clinical Oncology, vol. 21, no. 19, pp. 3623–3628, 2003. View at Publisher · View at Google Scholar
  5. R. Adam, V. Delvart, G. Pascal et al., “Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival,” Annals of Surgery, vol. 240, no. 4, pp. 644–658, 2004. View at Publisher · View at Google Scholar
  6. R. Adam, E. Avisar, A. Ariche et al., “Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases,” Annals of Surgical Oncology, vol. 8, no. 4, pp. 347–353, 2001. View at Publisher · View at Google Scholar
  7. S. Ambiru, M. Miyazaki, T. Isono et al., “Hepatic resection for colorectal metastases: analysis of prognostic factors,” Diseases of the Colon and Rectum, vol. 42, no. 5, pp. 632–639, 1999. View at Publisher · View at Google Scholar
  8. K. T. E. Beckurts, A. H. Hölscher, S. T. Thorban, E. Bollschweiler, and J. R. Siewert, “Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases,” British Journal of Surgery, vol. 84, no. 8, pp. 1081–1084, 1997. View at Publisher · View at Google Scholar
  9. E. L. A. R. Mutsaerts, S. van Ruth, F. A. N. Zoetmulder, E. J. T. Rutgers, A. A. M. Hart, and F. van Coevorden, “Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience,” Journal of Gastrointestinal Surgery, vol. 9, no. 2, pp. 178–186, 2005. View at Publisher · View at Google Scholar
  10. I. Vassiliou, N. Arkadopoulos, T. Theodosopoulos et al., “Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations,” World Journal of Gastroenterology, vol. 13, no. 9, pp. 1431–1434, 2007. View at Google Scholar
  11. T. M. Pawlik, C. R. Scoggins, D. Zorzi et al., “Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases,” Annals of Surgery, vol. 241, no. 5, pp. 715–724, 2005. View at Publisher · View at Google Scholar
  12. H. Ueno, H. Mochizuki, Y. Hashiguchi, K. Hatsuse, H. Fujimoto, and K. Hase, “Predictors of extrahepatic recurrence after resection of colorectal liver metastases,” British Journal of Surgery, vol. 91, no. 3, pp. 327–333, 2004. View at Publisher · View at Google Scholar
  13. M. S. Rodgers and J. L. McCall, “Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review,” British Journal of Surgery, vol. 87, no. 9, pp. 1142–1155, 2000. View at Publisher · View at Google Scholar
  14. E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J.-N. Vauthey, and D. Mahvi, “Improving resectability of hepatic colorectal metastases: expert consensus statement,” Annals of Surgical Oncology, vol. 13, no. 10, pp. 1271–1280, 2006. View at Publisher · View at Google Scholar
  15. C. Laurent, A. Sa Cunha, E. Rullier, D. Smith, A. Rullier, and J. Saric, “Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis,” Journal of the American College of Surgeons, vol. 198, no. 6, pp. 884–891, 2004. View at Publisher · View at Google Scholar
  16. D. Jaeck, H. Nakano, P. Bachellier et al., “Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study,” Annals of Surgical Oncology, vol. 9, no. 5, pp. 430–438, 2002. View at Publisher · View at Google Scholar
  17. A. Tocchi, G. Mazzoni, S. Brozzetti, M. Miccini, D. Cassini, and E. Bettelli, “Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome,” International Journal of Colorectal Disease, vol. 19, no. 6, pp. 580–585, 2004. View at Publisher · View at Google Scholar
  18. N. Kokudo, M. Seki, H. Ohta et al., “Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases,” Annals of Surgical Oncology, vol. 5, no. 8, pp. 706–712, 1998. View at Publisher · View at Google Scholar
  19. N. Kemeny, W. Jarnagin, P. Paty et al., “Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer,” Journal of Clinical Oncology, vol. 23, no. 22, pp. 4888–4896, 2005. View at Publisher · View at Google Scholar
  20. J. J. Bennett, D. Cao, and M. C. Posner, “Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases,” Journal of Surgical Oncology, vol. 92, no. 1, pp. 64–69, 2005. View at Publisher · View at Google Scholar
  21. A. Falcone, S. Ricci, I. Brunetti et al., “Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest,” Journal of Clinical Oncology, vol. 25, no. 13, pp. 1670–1676, 2007. View at Publisher · View at Google Scholar
  22. N. E. Kemeny, D. Niedzwiecki, D. R. Hollis et al., “Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481),” Journal of Clinical Oncology, vol. 24, no. 9, pp. 1395–1403, 2006. View at Publisher · View at Google Scholar
  23. H. Imamura, Y. Matsuyama, R. Shimada et al., “A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma,” American Journal of Gastroenterology, vol. 96, no. 11, pp. 3178–3184, 2001. View at Publisher · View at Google Scholar
  24. T. Irie, Y. Itai, K. Hatsuse, and H. Mochizuki, “Does resection of small liver metastases from colorectal cancer improve survival of patients?” British Journal of Radiology, vol. 72, no. 855, pp. 246–249, 1999. View at Google Scholar
  25. D. Jaeck, “The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies,” Annals of Surgical Oncology, vol. 10, no. 9, pp. 1007–1011, 2003. View at Publisher · View at Google Scholar
  26. T. E. Clancy, E. Dixon, R. Perlis, F. R. Sutherland, and M. J. Zinner, “Hepatic arterial infusion after curative resection of colorectal cancer metastases: a meta-analysis of prospective clinical trials,” Journal of Gastrointestinal Surgery, vol. 9, no. 2, pp. 198–206, 2005. View at Publisher · View at Google Scholar
  27. H. Bismuth, R. Adam, F. Navarro, D. Castaing, L. Engerran, and A. Abascal, “Re-resection for colorectal liver metastasis,” Surgical Oncology Clinics of North America, vol. 5, no. 2, pp. 353–364, 1996. View at Google Scholar
  28. S. Nakamura, Y. Yokoi, S. Suzuki, S. Baba, and H. Muro, “Results of extensive surgery for liver metastases in colorectal carcinoma,” British Journal of Surgery, vol. 79, no. 1, pp. 35–38, 1992. View at Publisher · View at Google Scholar
  29. J. Harms, T. Obst, S. Thorban et al., “The role of surgery in the treatment of liver metastases for colorectal cancer patients,” Hepato-Gastroenterology, vol. 46, no. 28, pp. 2321–2328, 1999. View at Google Scholar
  30. “RevMan Analyses [Computer program]: Version 1.0 for Windows,” In: Review Manager (RevMan). Version 4.2 for Windows, The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark, 200.
  31. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Publisher · View at Google Scholar
  32. D. L. Demets, “Methods for combining randomized clinical trials: strengths and limitations,” Statistics in Medicine, vol. 6, no. 3, pp. 341–348, 1987. View at Publisher · View at Google Scholar
  33. J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar
  34. “StatsDirect statistical software (version 2.4.5),” 2005.
  35. K. Yasui, T. Hirai, T. Kato et al., “Major anatomical hepatic resection with regional lymph node dissection for liver metastases from colorectal cancer,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 2, no. 2, pp. 103–107, 1995. View at Publisher · View at Google Scholar
  36. B. Nordlinger, D. Jaeck, M. Guiguet, J. C. Vaillant, P. Balladur, and J. C. Schaal, “Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery,” in Treatment of Hepatic Metastases of Colorectal Cancer, B. Nordlinger and B. Jaeck, Eds., pp. 129–146, Springer, Paris, France, 1992. View at Google Scholar
  37. M. Sanchez-Cespedes, M. Esteller, K. Hibi et al., “Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence,” Clinical Cancer Research, vol. 5, no. 9, pp. 2450–2454, 1999. View at Google Scholar
  38. H. H. Hartgritik, C. J. H. van de Velde, H. Putter et al., “Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized dutch gastric cancer group trial,” Journal of Clinical Oncology, vol. 22, no. 11, pp. 2069–2077, 2004. View at Publisher · View at Google Scholar
  39. L. Capussotti, A. Muratore, M. M. Mulas, P. Massucco, and M. Aglietta, “Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases,” British Journal of Surgery, vol. 93, no. 8, pp. 1001–1006, 2006. View at Publisher · View at Google Scholar
  40. Y. Tsuchiya, M. Onda, K. Sasajima et al., “Effects of preoperative chemotherapy on metastatic lymph nodes in esophageal squamous cell carcinoma,” Diseases of the Esophagus, vol. 15, no. 3, pp. 226–231, 2002. View at Publisher · View at Google Scholar
  41. M. Yano, K. Takachi, Y. Doki et al., “Preoperative chemotherapy for clinically node-positive patients with squamous cell carcinoma of the esophagus,” Diseases of the Esophagus, vol. 19, no. 3, pp. 158–163, 2006. View at Publisher · View at Google Scholar
  42. M. W. Onaitis, R. B. Noone, M. Hartwig et al., “Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience,” Annals of Surgery, vol. 233, no. 6, pp. 778–785, 2001. View at Publisher · View at Google Scholar
  43. F. Stipa, A. Zernecke, H. G. Moore et al., “Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?” Annals of Surgical Oncology, vol. 11, no. 2, pp. 187–191, 2004. View at Publisher · View at Google Scholar